top of page
birmingham-alabama-usa-downtown-city-skyline-dusk.jpg

IN THE STATES

ALABAMA

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Alabama in 2022.

AL.png

Economic
Output

$5.3B

Direct Jobs Supported by the Industry

4,168

Total Jobs Supported

17,945

State Total Vendor Relationships

290

State Total Vendor Spending

$140,894,282

Clinical
Trials

664

Investments at Clinical Trial Sites

$273M

Clinical Trial Participants

14,062

Total Economic Impact of Clinical Trial Sites

$672.8M

bottom of page